Is It Worthwhile For Investors To Follow These Insider Trades On Revance Therapeutics Inc (RVNC)?
Revance Therapeutics Inc (NASDAQ:RVNC) traded with a subtraction of -$0.26 to $11.83 on Thursday, a downside of -2.15 percent. An average of 2,164,518 shares of common stock have been traded in the last five days. There was a fall of -$0.70 in the past week, and it reached a new high 16 times over the […]
An Insider Sold 11,000 Shares Of Revance Therapeutics Inc. (RVNC)
As of Friday close, Revance Therapeutics Inc.’s (NASDAQ:RVNC) stock was up $0.54, moving up 4.33 percent to $13.01. The average number of shares traded per day over the past five days has been 5,564,840 shares. 1 time new highs have been achieved over the past 5 days, with a -$3.79 fall in that time frame. […]
Views On Revance Therapeutics Inc. (RVNC) From A Technical Perspective
The stock of Revance Therapeutics Inc. (NASDAQ:RVNC) decreased by -$2.89 on Tuesday to finish at $13.81, down -17.31 percent. The last five days have seen an average of 4,233,360 shares of common stock traded. 13 times new highs were reached in the current year, with a fall of -$4.65. The average number of shares traded […]
Revance Therapeutics Inc. (RVNC) Price Targets: What Do They Mean?
As of Wednesday close, Revance Therapeutics Inc.’s (NASDAQ:RVNC) stock was down -$0.4, moving down -2.19 percent to $17.87. The average number of shares traded per day over the past five days has been 925,900 shares. 2 times new highs have been achieved over the past 5 days, with a -$0.74 fall in that time frame. […]
Views On Revance Therapeutics Inc. (RVNC) From A Technical Perspective
The stock of Revance Therapeutics Inc. (NASDAQ:RVNC) decreased by -$0.06 on Friday to finish at $18.50, down -0.32 percent. The last five days have seen an average of 1,257,760 shares of common stock traded. 13 times new highs were reached in the current year, with a gain of $0.04. The average number of shares traded […]
A Technical View of the Revance Therapeutics Inc. (RVNC)
Revance Therapeutics Inc. (NASDAQ:RVNC) saw an upside of 1.94% to close Tuesday at $17.89 after adding $0.34 on the day. The 5-day average trading volume is 1,441,760 shares of the company’s common stock. It has gained $19.08 in the past week and touched a new high 1 time within the past 5 days. An average […]
How Revance Therapeutics Inc. (RVNC) Works From A Technical Perspective
Revance Therapeutics Inc. (NASDAQ:RVNC) finished Wednesday with a subtraction of -$1.77 to close at $20.22, a downside of -8.05 percent. An average of 2,246,000 shares of common stock have been traded in the last five days. There was a fall of -$1.87 in the past week, and it reached a new high 16 times over […]
Weekly Performance Analysis for Revance Therapeutics Inc. (RVNC)
Revance Therapeutics Inc. (NASDAQ:RVNC) saw a downside of -4.22% to $21.79 after subtracting -$0.96 on Monday. The 5-day average trading volume is 1,192,869 shares of the company’s common stock. It has gained $23.53 in the past week and touched a new high 1 time within the past 5 days. An average of 1,170,512 shares of […]
